Advertisement
Organisation › Details
BioMedPartners (Group)
Based in Basel, Switzerland, BioMedPartners is an independent European venture capital firm that acts as lead-or co-lead investor providing private equity to early-to mid-stage life sciences companies. Since 2002, BioMedPartners has invested in several highly innovative companies of which twenty-two have already either successfully been acquired by leading biopharma companies or have completed an IPO. With more than CHF 350 million in capital under management and a strong team of experienced industry experts as well as an extensive scientific and pharma network, BioMedPartners has established itself as one of the leading early-stage human healthcare investors in Europe. In February 2018, the company announced the closing of BioMedInvest III, their third equity venture capital fund of CHF 100 million. In this third fund BioMedPartners is focusing on the build-up of companies with highly innovative early stage assets and technology platforms. The first investment of BioMedInvest III was in the Swiss immuno-oncology company Amal SA (Geneva) which has been acquired by Boehringer Ingelheim in June 2019. *
Start | 2009-03-13 renamed | |
Predecessor | BioMedInvestor (Group) | |
Industry | venture capital | |
Industry 2 | BIOTECH | |
Person | Hosang, Markus (BioMedPartners 201108 General Partner) | |
Person 2 | Fischer, Karsten (Memo Therapeutics 201806–202311 CEO before BioMedPartners + WestLB LEFT 11/23) | |
Region | Basel BS | |
Country | Switzerland | |
Street | 23 Elisabethenstr. | |
City | 4051 Basel BS | |
Tel | +41-61-270-3535 | |
Address record changed: 2022-06-11 | ||
Basic data | Employees | n. a. |
Currency | CHF | |
Annual sales | 350,000,000 (capital under management 2020-10-19) | |
* Document for »About Section«: Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing". Hamburg. | ||
Record changed: 2023-06-26 |
Advertisement
More documents for BioMedPartners (Group)
- [1] Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris....
- [2] Topas Therapeutics GmbH. (7/29/21). "Press Release: Topas Therapeutics Extends Series B, Raising Total of €40 Million (~$ 48 Million) in this Round". Hamburg....
- [3] Tubulis GmbH. (7/21/20). "Press Release: Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates". Munich....
- [4] Tolremo Therapeutics AG. (6/9/20). "Press Release: Tolremo Receives Additional CHF 4.7M in Series A Financing, Bringing Total Series A Round to CHF 13.7M". Muttenz....
- [5] Alentis Therapeutics AG. (4/30/19). "Press Release: Alentis Therapeutics Launches, Raising CHF 12.5m in a Series A to Develop Novel Therapeutics in Advanced Liver Disease and Cancer". Basel....
- [6] Tolremo Therapeutics AG. (9/24/18). "Press Release: Tolremo Raises CHF 9 Million Series A Financing Round and Strengthens Board of Directors with Industry Experts". Zurich....
- [7] Memo Therapeutics AG. (6/11/18). "Press Release: Memo Therapeutics AG Announced that Dr. Karsten Fischer Was Appointed as Chief Executive Officer of the Company Effective June 01, 2018". Basel....
- [8] BioMedPartners AG. (3/1/18). "Press Release: BioMedPartners Close Their New Healthcare Venture Fund BioMedInvest III at CHF 100 Million". Basel....
- [9] Amal Therapeutics S.A.. (9/5/17). "Press Release: Amal Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round". Geneva....
- [10] BioMedPartners AG. (2/16/17). "Press Release: BioMedPartners Raise CHF 75 Million in First Closing of Their New Healthcare Venture Fund". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top